Lipomics Technologies, Inc. to Partner With University of California, San Diego (UCSD) in Insulin Resistance and Weight Loss Research

WEST SACRAMENTO, CA--(MARKET WIRE)--Jul 16, 2007 -- Lipomics Technologies, Inc., a privately held company that specializes in clinical diagnostic development, announced today that it has entered into an agreement with The University of California, San Diego. The collaboration will focus on clinical investigations aimed at identifying mechanisms underlying the pathogenesis of non-insulin dependent diabetes mellitus (NIDDM), obesity, and other disorders of insulin resistance. Studies are also in progress to identify the relative role of each organ system (muscle, liver and fat) to the pathophysiology of NIDDM.